Novelgen
Find Us
← Back to list

CG Oncology drug delivers ‘exceptional’ results in key bladder cancer trial

BioPharma DiveBen FidlerNovember 16, 2026
CG s therapy cretostimogene cut the risk of recurrence by 68% when administered after surgery, far surpassing Wall Street s expectations and lifting company shares.
Read original article
← Back to list